Letter: Faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 8, 2015, Pages 1030-

  Pecere, S ^a   Sabatelli, M ^a   Fantoni, M ^b   Ianiro, G ^a   Gasbarrini, A ^a   Cammarota, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIDAXOMICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; BIOLOGICAL THERAPY; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; FECES MICROFLORA; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; MALE; PROCEDURES;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMANS; MALE; VANCOMYCIN;

EID: 84941637930     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13362     Document Type: Letter

References (3)

1. Fischer M, Sipe BW, Rogers NA, et al., Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther 2015; 42: 470-6.
2. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y,. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364: 422-31.
3. Cammarota G1, Masucci L, Ianiro G, et al., Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015; 41: 835-43.